These findings reveal the neuroprotective effect of RUVBL2 knockdown against the progression of PND, providing a potential therapeutic target for mitigating cognitive decline associated with anesthetics interventions in aged MCI patients. This evidence concerns the gene RUVBL2 and Mental deterioration.